바디텍메드

206640KOSDAQ의료용품 및 기타 의약 관련제품 제조업

55.0 / 100

Reference Date: 2026-04-13

Financial Score26.5 / 40

News Sentiment12.5 / 25

Momentum4.0 / 20

Disclosure12.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but Operating Profit metrics are weak. Declined 13.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Bodytekmed operates two business segments: immune diagnostic cartridges and diagnostic devices. It supplies a wide range of products, including CRP, PCT, and D-Dimer cartridges, as well as ichroma and AFIAS series diagnostic equipment, to global markets. Following the COVID-19 pandemic, the company expanded its antigen testing products and continues to launch high-value items like ST2 and TDM diagnostic kits. The AFIAS series, featuring automated functionality, is expected to drive sales growth due to enhanced user convenience.

Number of Employees

601people

Average Salary

49.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.47Industry Average 19.896.5Point

Lower than industry avg (good)

PBR

1.02Industry Average 1.625.5Point

Lower than industry avg (good)

ROE

10.22Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

5.76Industry Average 8.885.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.1% (2-year basis)

Operating Profit Growth Rate

1.0 / 3

Avg ▲1.3% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 12.5% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Neutral
바디텍메드, 31일 배당락 발생
바디텍메드는 오는 31일 배당락이 발생하며, 기준가는 1만1330원입니다.
Neutral
강원후평스마트그린산단 AX마스터플랜 수립 연구용역 착수보고회 26일.....
강원후평스마트그린산단 AX마스터플랜 수립 연구용역 착수보고회가 개최되었으나, 바디텍메드와의 직접적인 연관성은 명확하지 않습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 11,420Won52-week high 18,04052-week low 10,510

1-month return1.0Point

1m -13.22% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

9 totalPositive 1Neutral 8Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
Neutral주식등의대량보유상황보고서(일반)2026-04-07
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
Positive배당락2026-03-30